Mark Sheptoff Financial Planning LLC decreased its stake in HealthEquity, Inc. (NASDAQ:HQY) by 0.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,950 shares of the company’s stock after selling 1 shares during the period. Mark Sheptoff Financial Planning LLC’s holdings in HealthEquity were worth $396,000 as of its most recent filing with the SEC.

Several other large investors also recently added to or reduced their stakes in HQY. Vanguard Group Inc. raised its stake in HealthEquity by 6.2% in the first quarter. Vanguard Group Inc. now owns 4,115,237 shares of the company’s stock valued at $174,691,000 after buying an additional 240,136 shares in the last quarter. Paloma Partners Management Co bought a new stake in HealthEquity during the first quarter valued at $503,000. AQR Capital Management LLC raised its stake in HealthEquity by 635.3% in the first quarter. AQR Capital Management LLC now owns 53,178 shares of the company’s stock valued at $2,257,000 after buying an additional 45,946 shares in the last quarter. Quantbot Technologies LP raised its stake in HealthEquity by 83.4% in the first quarter. Quantbot Technologies LP now owns 6,883 shares of the company’s stock worth $292,000 after buying an additional 3,129 shares during the last quarter. Finally, Bank of America Corp DE raised its stake in HealthEquity by 57.6% in the first quarter. Bank of America Corp DE now owns 86,183 shares of the company’s stock worth $3,659,000 after buying an additional 31,500 shares during the last quarter. 91.86% of the stock is owned by institutional investors and hedge funds.

HealthEquity, Inc. (NASDAQ HQY) traded up 2.57% during trading on Thursday, reaching $42.68. The company’s stock had a trading volume of 86,693 shares. HealthEquity, Inc. has a 52 week low of $30.34 and a 52 week high of $54.95. The company has a market cap of $2.56 billion, a P/E ratio of 80.23 and a beta of 1.73. The company’s 50 day moving average price is $46.96 and its 200 day moving average price is $45.88.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, June 6th. The company reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.03. HealthEquity had a net margin of 17.04% and a return on equity of 11.61%. The business had revenue of $55.40 million for the quarter, compared to analysts’ expectations of $54.77 million. During the same period in the previous year, the company earned $0.15 earnings per share. The firm’s revenue for the quarter was up 25.9% compared to the same quarter last year. On average, equities analysts anticipate that HealthEquity, Inc. will post $0.59 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This article was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.watchlistnews.com/mark-sheptoff-financial-planning-llc-decreases-stake-in-healthequity-inc-hqy/1534247.html.

A number of analysts have recently issued reports on HQY shares. TheStreet upgraded HealthEquity from a “c” rating to a “b” rating in a report on Monday, July 31st. Zacks Investment Research lowered HealthEquity from a “buy” rating to a “hold” rating in a report on Friday, August 4th. BidaskClub lowered HealthEquity from a “hold” rating to a “sell” rating in a report on Thursday, August 3rd. Cantor Fitzgerald restated a “buy” rating and issued a $56.00 target price on shares of HealthEquity in a report on Tuesday. Finally, Chardan Capital increased their target price on HealthEquity from $53.00 to $57.00 and gave the company a “buy” rating in a report on Wednesday, June 7th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. HealthEquity currently has an average rating of “Buy” and an average price target of $50.22.

In other HealthEquity news, Director Frank Medici sold 210,906 shares of HealthEquity stock in a transaction dated Wednesday, June 14th. The shares were sold at an average price of $52.03, for a total value of $10,973,439.18. Following the sale, the director now owns 6,381 shares of the company’s stock, valued at $332,003.43. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Jon Soldan sold 25,000 shares of HealthEquity stock in a transaction dated Monday, August 28th. The stock was sold at an average price of $40.68, for a total transaction of $1,017,000.00. Following the completion of the sale, the vice president now directly owns 30,652 shares in the company, valued at approximately $1,246,923.36. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 2,483,821 shares of company stock worth $127,137,793. 29.00% of the stock is owned by corporate insiders.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.